Arthur Cox advised Bristol Myers Squibb on the deal. Bristol Myers Squibb finalized a successful sale of its two Irish-authorised captive insurance undertakings, BMS International Insurance...
You must be a Standard 1 Year member to access this content.
Arthur Cox represented Chanelle Pharma on the transaction. Exponent completed the acquisition of Chanelle Pharma, Ireland’s largest indigenous generic pharmaceutical manufacturer of both medical and veterinary products....
You must be a Standard 1 Year member to access this content.
Arthur Cox advised ArisGlobal on the deal. ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Cognizant on its acquisition of TQS Integration Limited. Cognizant (Nasdaq: CTSH) agreed to acquire TQS Integration, a privately owned global industrial data and intelligence company...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, working closely to Arthur Cox, represented Dole in the offering, while Latham & Watkins represented the underwriters. Dole plc, a newly...
You must be a Standard 1 Year member to access this content.
